Companies › INMB

INMUNE BIO INC (INMB)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001711754 · EDGAR filings · Updated 2026-07-07

INMUNE BIO INC (INMB) has reported institutional ownership of 20.2%, with 81 institutional managers holding positions valued at $6.08M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-01 — Current report (8-K) filed
• 2026-06-23 — Current report (8-K) filed
• 2026-06-17 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INMUNE BIO INC has 81 institutional holders and institutional ownership of 20.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

MEDICUS PHARMA LTD (MDCX) · NERVGEN PHARMA CORP (NGEN) · HEARTBEAM INC (BEAT) · APOLLOMICS INC (APLM) · CYPHERPUNK TECHNOLOGIES INC (CYPH) · Scilex Holding Co (SCLX)